Interleukin 33, released with hepatectomy, facilitated recurrent disease of cholangiocarcinoma

被引:0
|
作者
Nagaoka, Satoshi [1 ]
Yamada, Daisaku [1 ]
Eguchi, Hidetoshi [1 ]
Iwagami, Yoshifumi [1 ]
Akita, Hirofumi [1 ]
Asaoka, Tadafumi [1 ]
Noda, Takehiro [1 ]
Gotoh, Kunihito [1 ]
Kobayashi, Shogo [1 ]
Umeshita, Koji [2 ]
Doki, Yuichiro [1 ]
Mori, Masaki [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, Suita, Osaka, Japan
[2] Osaka Univ, Grad Sch Med, Div Hlth Sci, Suita, Osaka, Japan
来源
CANCER SCIENCE | 2018年 / 109卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
J-2075
引用
收藏
页码:718 / 718
页数:1
相关论文
共 50 条
  • [1] IL-33, Released with Hepatectomy, Facilitated Recurrence of Cholangiocarcinoma Not through Direct Influence
    Nagaoka, S.
    Yamada, D.
    Eguchi, H.
    Iwagami, Y.
    Asaoka, T.
    Noda, T.
    Wada, H.
    Kawamoto, K.
    Gotoh, K.
    Doki, Y.
    Mori, M.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S110 - S110
  • [2] The blockade of interleukin-33 released by hepatectomy would be a promising treatment option for cholangiocarcinoma
    Nagaoka, Satoshi
    Yamada, Daisaku
    Eguchi, Hidetoshi
    Yokota, Yuki
    Iwagami, Yoshifumi
    Asaoka, Tadafumi
    Noda, Takehiro
    Kawamoto, Koichi
    Gotoh, Kunihito
    Kobayashi, Shogo
    Miyoshi, Eiji
    Doki, Yuichiro
    Mori, Masaki
    CANCER SCIENCE, 2021, 112 (01) : 347 - 358
  • [3] IL-33, released with hepatectomy, facilitated CCA prognosis
    Yamada, Daisaku
    Eguchi, Hidetoshi
    Nagaoka, Satoshi
    Iwagami, Yoshifumi
    Asaoka, Tadafumi
    Noda, Takehiro
    Wada, Hiroshi
    Kawamoto, Koichi
    Gotoh, Kunihito
    Doki, Yuichiro
    Mori, Masaki
    HEPATOLOGY, 2016, 64 : 654A - 654A
  • [4] Interleukin-33 keeping liver facilitated recurrence of cholangiocarcinoma through indirect influence
    Nagaoka, Satoshi
    Yamada, Daisaku
    Eguchi, Hidetoshi
    Iwagami, Yoshifumi
    Asaoka, Tadafumi
    Noda, Takehiro
    Kawamoto, Koichi
    Gotoh, Kunihito
    Kobayashi, Syogo
    Umeshita, Koji
    Doki, Yuichiro
    Mori, Masaki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 41 - 41
  • [5] RIGHT HEPATECTOMY FOR RECURRENT HILAR CHOLANGIOCARCINOMA
    Li, Xiangcheng
    GASTROENTEROLOGY, 2017, 152 (05) : S1219 - S1219
  • [6] Repeated hepatectomy for recurrent intrahepatic cholangiocarcinoma: report of two cases
    Kurosaki, I
    Hatakeyama, K
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (01) : 125 - 130
  • [7] Hepatectomy or/with Metastatectomy for Recurrent Intrahepatic Cholangiocarcinoma: Of Promise for Selected Patients
    Tsai, Chun-Yi
    Wang, Shang-Yu
    Chan, Kun-Ming
    Lee, Wei-Chen
    Chen, Tse-Ching
    Yeh, Ta-Sen
    Jan, Yi-Yin
    Yeh, Chun-Nan
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (04):
  • [8] Prognostic factors of recurrent intrahepatic cholangiocarcinoma after hepatectomy: A retrospective study
    Yuan, Zi-Bo
    Fang, Hong-Bo
    Feng, Quan-Kai
    Li, Tao
    Li, Jie
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (15) : 1574 - 1587
  • [9] Prognostic factors of recurrent intrahepatic cholangiocarcinoma after hepatectomy: A retrospective study
    Zi-Bo Yuan
    Hong-Bo Fang
    Quan-Kai Feng
    Tao Li
    Jie Li
    World Journal of Gastroenterology, 2022, (15) : 1574 - 1587
  • [10] Interleukin-33 in health and disease
    Liew, Foo Yew
    Girard, Jean-Philippe
    Turnquist, Heth Roderick
    NATURE REVIEWS IMMUNOLOGY, 2016, 16 (11) : 676 - 689